Medical/Pharmaceuticals
Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants
* SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST * COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS * S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS SEOUL, South Korea, Feb. 1, 2021 /PRNewswire/ -- South Korea's biotechnology firm Seegene (KQ096530) said Monday it ...
2021-02-01 13:05
3956
Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator
- Cytiva will now provide "idea to injection" solutions to customers and the market - Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies - First acquisition by company since becoming Cytiva in April 2020 AMERSHAM, United Kingdom, ...
2021-02-01 13:01
4162
INEOS Styrolution Receives "2020 Public Welfare Practice Award" at the 10th China Charity Festival
SINGAPORE, Feb. 1, 2021 /PRNewswire/ -- INEOS Styrolution, the global leader in
styrenics, today announces that it has been awarded the "2020 Public Welfare
Practice Award" at the 10th China Charity Festival held on 29th January 2021, in
Shanghai.
2021-02-01 09:00
3713
Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage
SHANGHAI and HONG KONG, Feb. 1, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...
2021-02-01 08:09
5576
DWHP Announces Expiration And Final Results Of Its Cash Tender Offer For All Outstanding Ordinary Shares Of Parnell Pharmaceuticals Holdings Ltd.
PARK CITY, Utah, Jan. 30, 2021 /PRNewswire/ -- DW Healthcare Partners V, L.P. ("DWHP"), announced today the expiration and final results of its previously announced cash tender offer (the "Tender Offer") to purchase all of the outstanding ordinary shares (the "Tender Securities") of Parnell Phar...
2021-01-30 07:38
9586
Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA
BEIJING and BRIDGEWATER, N.J., Jan. 29, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation fo...
2021-01-29 22:53
8707
RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib
TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-01-29 20:26
6961
Nippon Express Bangladesh Obtains GDP Certification for Air Cargo Import/Export Services
TOKYO, Jan. 29, 2021 /PRNewswire/ -- Nippon Express Bangladesh Ltd. (hereinafter, "NE Bangladesh"), a local subsidiary of Nippon Express Co., Ltd. based inTokyo, has obtained Good Distribution Practice (GDP) certification effectiveSunday, December 13, 2020, evidencing its compliance with standard...
2021-01-29 15:00
1909
2021 Japan Prize Laureates Announced
TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced onJanuary 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy...
2021-01-29 14:00
1418
Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company
SUZHOU, China and ROCKVILLE, Md., Jan. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...
2021-01-29 08:29
2759
12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC
NYON, Switzerland, Jan. 29, 2021 /PRNewswire/ -- 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAllianc...
2021-01-29 01:46
1465
RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals
TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill
Biopharma Ltd.
2021-01-28 22:03
5915
Immunoforge's 'PF1801' Is Designated as Orphan Drug by FDA
SEOUL, South Korea, Jan. 28, 2021 /PRNewswire/ -- Immunoforge, the company specializing in the development of new drugs for rare musculoskeletal diseases (Representatives: An Seong-Min and Jang Gi-Ho), announced that their new drug candidate PF1801 has been designated as the FDA orphan drug for t...
2021-01-28 22:00
2217
"Right to Work" Is Theme of 16th Global Appeal to End Stigma and Discrimination against Persons Affected by Leprosy to Be Launched with Endorsement of International Trade Union Confederation
TOKYO and BRUSSELS, Jan. 28, 2021 /PRNewswire/ -- The 16th Global Appeal to End
Stigma and Discrimination against Persons Affected by Leprosy will be launched
in an online ceremony onJanuary 31, 2021, World Leprosy Day.
2021-01-28 22:00
1583
Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged
VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. T...
2021-01-28 21:46
5713
Zeus Launches Reinforced Polyimide Tubing
Expanded Capabilities Help Customers Consolidate Suppliers, Innovate, and Go to Market With Confidence ORANGEBURG, S.C., Jan. 28, 2021 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, announced today that it has added bra...
2021-01-28 21:00
1733
Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil
SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the clinical trial (the "Trial") of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board ("IRB") ofBrazil. The trial was accept...
2021-01-28 19:57
6979
CROMSOURCE Consolidates Strategic Site Support Service
VERONA, Italy, Jan. 28, 2021 /PRNewswire/ -- CROMSOURCE, an international contract research organization (CRO), announced today the expansion of its Strategic Site Support Service that can be provided to sites participating in clinical research studies managed by CROMSOURCE on behalf of companies...
2021-01-28 19:00
2696
Sai Life Sciences announces plans to double headcount and expand capabilities in Manchester, UK
MANCHESTER, England and HYDERABAD, India, Jan. 28, 2021 /PRNewswire/ -- Sai
Life Sciences, one ofIndia's fastest growing Contract Research, Development &
Manufacturing Organizations
2021-01-28 15:30
3595
Harbour BioMed's Batoclimab (HBM9161) Receives China CDE Breakthrough Therapy Designation for Treatment of Adult Patients with Myasthenia Gravis
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Harbour BioMed (HBM) (HKEX: 02142.HK), announced today that China Center for Drug Evaluation (CDE) has granted Breakthrough Therapy designation to Batoclimab (HBM 9161), a fully human anti-FcRn monoclonal a...
2021-01-28 12:54
7980
Week's Top Stories
Most Reposted
Radisson Hotel Group accelerates growth in Indonesia with ANTA Hotel Bali Canggu, a member of Radisson Individuals
[Picked up by 313 media titles]
2025-12-10 10:00
HKSTP Makes Strategic Investment in Singapore Technology Company Vizzio; Forges Innovation Pact to Power Next-Generation AI and Smart City
[Picked up by 306 media titles]
2025-12-09 13:31
ARKANCE to Launch BIMLOGIQ - A New AI-Powered Extension to Its AEC Tech Stack Offering
[Picked up by 293 media titles]
2025-12-11 09:07
BeLive Studios, NewUnivers and ChopChop Systems Sign Memorandum of Understanding at ATF 2025
[Picked up by 288 media titles]
2025-12-08 11:00
Tiiny AI Reveals World's Smallest Personal AI Supercomputer, Verified by Guinness World Records
[Picked up by 285 media titles]
2025-12-10 16:00
